P RODUCT S
Integrated workflow solution links data and decision-making to support quality care
The Canexis Integrated Workflow Solution from CANTEL links data and decision- making to support the efficient operation of critical hospital departments. The endoscopy solution allows Trusts to monitor every step of the patient’s experience to support quality patient care.
The traceability, ownership and accountability that the software delivers
helps to support patient safety and infection prevention. The solution was developed in close collaboration with endoscopy experts to create a high-quality, user-friendly tool that ensures best practice. It is also flexible and configurable to support workflow needs. It allows healthcare providers to deter- mine the real-time status and location of the entire endoscope inventory at a glance with a monitoring dashboard. It also provides valuable information on which endoscopes are ready for use, which endoscopes need to be reprocessed, as well as tracking which endoscopes are out for repair. Other features include the ability to identify trends over time to help make repair vs. replace decisions. The solution is also available for sterilisation and surgical departments.
Hydrogen peroxide vapour technology
Using low concentration hydrogen peroxide vapour (HPV) delivered by vapour dispersal technology, the ProXcide, can achieve >log 6 reduc- tion of pathogenic micro-organisms – including highly resistant pathogens, such as C.difficile, making it ideal for healthcare settings that need to ensure high levels of efficacy. Using ProXcin 7.5% HPV, the
ProXcide provides a fully automated decontamination cycle, ensuring the same level of efficacy is achieved during every decontamination process. This effective method of decontamination has been advanced by INIVOS, which also offers ultraviolet-C (UV-C) technology. Once in the room it operates entirely automatically to reduce potential human error; the ProXcide decontamination robot is able to survey the environment and assess different variables to calculate how long it will need to decontaminate the space for.
The device also offers a high level of safety including a detailed checklist that cannot be bypassed by the users. ProXcide contains an integrated deactivation unit that quickly and efficiently deactivates hydrogen peroxide in the treatment room, providing reassurance and control over the process. The system is designed to work with a specially formulated low concentration hydrogen peroxide, ProXcin, which is developed to achieve high levels of efficacy without the risks associated with high concentration chemicals. The Wifi enabled touch screen device provided allows full visibility of the decontamination process during each stage, followed by a validation report to confirm that an effective decontamination cycle has been completed. With an average cycle time of just under two hours, the ProXcide is highly efficient – making it ideal for decontamination in a variety of clinical settings.
Innovative range of anaesthesia machines
MINDRAY’s latest A8 and A9 anaesthesia machines feature integrated high flow nasal cannula (HFNC) technology, which helps to extend the window of therapeutic action for anaesthetists by prolonging safe apnoeic oxygenation levels, allowing up to 30 minutes of safe oxygenated apnoea time. Studies have found that HFNC can more than double the average duration of apnoea before desaturation. Data from a wide range of external monitoring modules – such as bispectral index, neuromuscular
JANUARY 2021
transmission and intravenous imaging – can be seamlessly integrated and displayed by the new devices without any extra monitoring screens. Enabling anaesthetists to collect more data at a glance, the modular design also fulfils the need for fewer devices in the- atre, allowing anaesthetists to utilise a larger workspace and spend more time closely observing their patients. In order to optimise gas usage and quickly provide a balanced response to changes in patient status without user intervention, the A9 uses Automatic
Low temperature sterilisation solutions
LTE SCIENTIFIC has introduced a range of low temperature sterilisation products to aid the reprocessing of heat-sensitive medical devices and surgical instruments, including endoscopes, lumened/non-lumened instruments and surgical robotic instruments. The new products include the Matachana 50HPO and Matachana 130HPO low temperature hydrogen peroxide and plasma sterilisers, and the BluKat sterilising solution container for 130HPO and 50HPO sterilisers. The Matachana BluKat cartridges have an extended shelf life of 18 months, or 30 days once in use, and just one cartridge can provide enough sterilant for up to 30 cycles. Designed to ensure user safety, the sterilisers use vapourised hydrogen peroxide – a complementary method to steam sterilisation. They are claimed to be environmentally efficient in terms of energy usage and reduced utility consumption, as well as offering time savings. John Lees, managing director at LTE Scientific, said: “As specialists in the areas of decontamination for healthcare central sterilisation and endoscopy departments, we have recognised the growing need for effective low temperature sterilisation, and adding the Matachana HPO range to our portfolio means that we can now provide a fully integrated infection control solution for the medical industry.”
Controlled Anaesthesia (ACA). Through its precision electronic vaporiser and ACA platform, the A9 adjusts fresh gas and vaporiser output to hit patient targets using both end-tidal and inspiratory oxygen measurements.
WWW.CLINICALSERVICESJOURNAL.COM l 77
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80
